Rupert Egensperger Selected Research

Rupert Egensperger Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 06/2010
11	Glioma (Gliomas) 10/2022 - 02/2011
6	Alzheimer Disease (Alzheimer's Disease) 11/2012 - 08/2006
5	Glioblastoma (Glioblastoma Multiforme) 03/2023 - 02/2011
2	Astrocytoma (Pilocytic Astrocytoma) 10/2022 - 01/2022
2	Brain Neoplasms (Brain Tumor) 01/2022 - 11/2016
2	Oligodendroglioma 01/2022 - 06/2021
2	Amyloid Plaque 11/2012 - 08/2008
1	Disease Progression 10/2022
1	Meningioma (Meningiomas) 06/2019
1	Central Nervous System Vasculitis 11/2018
1	Neuroblastoma 09/2012
1	Nervous System Diseases (Neurological Disorders) 06/2012
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2012
1	Progressive Multifocal Leukoencephalopathy 01/2012
1	Peripheral Nervous System Diseases (PNS Diseases) 08/2010
1	Hyperalgesia 08/2010
1	Hyperplasia 08/2010
1	Chordoma 06/2010
1	Polyneuropathies (Polyneuropathy) 07/2009

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 11/2018 - 08/2008
4	Temozolomide (Temodar)FDA LinkGeneric 10/2022 - 02/2011
4	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2022 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2011
3	MethyltransferasesIBA 04/2021 - 02/2011
3	Messenger RNA (mRNA)IBA 05/2013 - 02/2011
3	Amyloid (Amyloid Fibrils)IBA 11/2012 - 08/2008
2	protoporphyrin IXIBA 04/2021 - 04/2013
2	AcidsIBA 04/2021 - 04/2013
2	Tyrosine (L-Tyrosine)FDA Link 01/2019 - 05/2015
2	Iodine-125IBA 11/2016 - 03/2016
2	Alkylating AgentsIBA 05/2013 - 02/2011
2	Cisplatin (Platino)FDA LinkGeneric 08/2010 - 07/2009
1	Photosensitizing Agents (Photosensitizers)IBA 04/2021
1	GadoliniumIBA 01/2019
1	Tacrolimus (Prograf)FDA LinkGeneric 11/2018
1	A-Form DNA (A-DNA)IBA 05/2013
1	EnzymesIBA 05/2013
1	MicroRNAs (MicroRNA)IBA 05/2013
1	(18F)fluoroethyltyrosineIBA 12/2012
1	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2012
1	S-Adenosylmethionine (Ademetionine)IBA 11/2012
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2012
1	ClusterinIBA 09/2012
1	fludarabineIBA 01/2012
1	Rituximab (Mabthera)FDA Link 01/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2012
1	2-toluenesulfonamide (OTS)IBA 11/2011
1	DNA (Deoxyribonucleic Acid)IBA 02/2011
1	Erythropoietin FDA Link 08/2010
1	tributyl phosphate (TBP)IBA 06/2010
1	Cathepsin DIBA 03/2010
1	Macrophage Migration-Inhibitory FactorsIBA 03/2010
1	Peptide Hydrolases (Proteases)FDA Link 03/2010
1	Amyloid beta-PeptidesIBA 08/2008
1	Plasminogen Activators (Plasminogen Activator)IBA 08/2006
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 08/2006

Therapy/Procedure

4	Radiotherapy 12/2019 - 02/2011
3	Photochemotherapy (Photodynamic Therapy) 03/2023 - 04/2013
3	Drug Therapy (Chemotherapy) 10/2022 - 05/2013
3	Therapeutics 01/2022 - 06/2019
2	Precision Medicine 01/2022 - 01/2022
2	Brachytherapy 11/2016 - 03/2016
1	Operative Surgical Procedures 01/2022
1	Salvage Therapy 11/2016
1	Aftercare (After-Treatment) 01/2012